Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection

Journal of Virology

Volumn 74, Issue 20, 2000, Pages 9655-9667

  Zsengeller, Z ^a   Otake, K ^a   Hossain, S A ^a   Berclaz, P Y ^a   Trapnell, B C ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREGULATION; INTERNALIZATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; TISSUE DISTRIBUTION; VIRUS CELL INTERACTION;

ACUTE DISEASE; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMAL; CALCIUM; CELL LINE; CYTOKINES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INFLAMMATION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; RESPIRATORY TRACT INFECTIONS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; VIRION;

EID: 0033809627     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.20.9655-9667.2000     Document Type: Article

References (63)

1. Differential cytokine expression in acute and chronic murine graft-versus-host-disease
2. Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys
3. A role for phosphoinositide 3-OH kinase in the completion of macropinocytosis and phagocytosis by macrophages
4. Histopathology of fatal adenovirus infection of the respiratory tract in young children
5. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
6. Pulmonary macrophages
7. Status of gene therapy for cystic fibrosis lung disease
8. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA
9. Persistent infection of human adenovirus type 5 in human monocyte cell lines
10. Cell number and cell characteristics of the normal human lung
11. Collectins and pulmonary host defense
12. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
13. Viral respiratory diseases
14. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia
15. The molecular basis of adenovirus pathogenesis
16. The role of the nuclear pore complex in adenovirus DNA entry
17. Stepwise dismantling of adenovirus 2 during entry into cells
18. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression
19. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection
20. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
21. Adenoviruses
22. 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery
23. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
24. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs
25. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor
26. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis
27. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB
28. Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells
29. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases
30. Adenovirus endocytosis via α(v) integrins requires phosphoinositide-3-OH kinase
31. The structural era of endocytosis
32. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles
33. IL-6 release and airway administration of human CFR cDNA adenovirus vector
34. Identification of multiple-molecular-weight forms of thymocyte comitogenic activity from the monocyte/macrophage cell line RAW 264.7
35. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
36. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5
37. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
38. +)-ATPase in animal virus entry
39. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)
40. Adenovirus uncoating and nuclear establishment are not affected by weak base amines
41. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
42. Adenovirus vaccines
43. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin
44. Adenovirus-mediated transfer of the cFTR gene to lung of nonhuman primates: Toxicity study
45. Microtubule-dependent plus and minus end-directed motilities are competing processes for nuclear targeting of adenovirus
46. A contractile activity that doses phagosomes in macrophages
47. Adenoviral vectors for gene transfer
48. Gene therapy for cystic fibrosis lung disease
49. A helper-independent adenovirus vector with E1, E3, and fiber deleted: Structure and infectivity of fiberless particles
50. Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo
51. Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta 5
52. Adenovirus internalization and infection require dynamin
53. Nonspecific host responses to viral infections
54. 5 promote adenovirus internalization but not virus attachment
55. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates
56. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract
57. Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA
58. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
59. Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung
60. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung
61. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats
62. Recombinant adenoviral vector disrupts surfactant homeostasis in mouse lung
63. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice